A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation.

The combination of all 4 biomarkers into a composite panel increased the AUC to 0.75 in the training cohort and to 0.90 in the validation cohort (supplemental Figure 4), although these improvements in AUC did not reach statistical significance.

also in 111,027 other papers

WFDC2 and IL-6 had increased hazard ratios (HRs), but did not quite reach statistical significance (supplemental Figure 2; supplemental Table 7).

also in 679 other papers